Case Activity (71)

1. Order | Filed: January 20, 2026 | Entered: January 20, 2026 AbbVie Inc. v. Genmab A/S et al

   Defend Trade Secrets Act (of 2016) | Washington Western

   2 - Minute Order

   MINUTE ORDER (text only) made at the direction of Judge Tana Lin: Pursuant to the stay ordered in this case (see Dkt. No. 52 ), the Motion to Stay Discovery (Dkt. No. 46 ) is DENIED as moot. As an exercise of the Court's inherent authority to manage its docket (see Dietz v. Bouldin, 579 U.S. 40, 47 (2016) (collecting cases)), Defendant's Motion to Dismiss (Dkt. No. 35 ) and all related filings (Dkt. Nos. 36 , 39 , 40 , 44 ) are hereby STRICKEN, with leave to refile after the stay is lifted, if appropriate. (CJS)

2. Order | Filed: January 16, 2026 AbbVie Inc. v. Genmab A/S et al

   Defend Trade Secrets Act (of 2016) | Washington Western

   Order

   ORDER granting Parties' 51 Stipulated Motion to Stay Proceedings Pending ITC Final Determination. This case is STAYED pending final resolution of the United States International Trade Commission's Investigation in In the Matte r of Certain Antibody Drug Conjugates and Components Thereof and Products Containing the Same, Inv. No. 337-TA-1466, including any and all appeals and until the ITC proceedings are no longer subject to judicial review. The parties shall provide a joint status update to the court by 5/31/2027, or within 14 days following the Target Date for the U.S. International Trade Commission's Investigation, whichever is sooner. Signed by Judge Tana Lin. (KRA)

3. 69 additional result(s)